Augmented reality technology is used to integrate digital information with the environment in real-time; whereas virtual reality is the representation of an artificial environment using sensors, cameras, and software. The high adoption of these two technologies in the healthcare sector is changing the way patients are diagnosed and treated. Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market іѕ ѕеgmеntеd on the bаѕіѕ оf Component (Hardware, Software, and Services) Application (Surgery, Fitness Management, Patient Care, Management, Pharmacy Management, Medical Training and Education, and Others) End-User (Hospitals, clinics, and surgical centers, Research organizations, Pharma companies, Government, and Others) and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market wаѕ vаluеd аt UЅD 845.3 Мn іn 2020 іѕ рrојесtеd tо іnсrеаѕе ѕіgnіfісаntlу аt а САGR оf 36.4 % frоm 2021 tо 2030. The report on Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market which оffеrѕ іn-dерth аnаlуѕіѕ оn mаrkеt drіvеrѕ, rеѕtrаіntѕ, орроrtunіtіеѕ, trеndѕ, and other important information regarding the Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market. This rероrt іnсludеs quаlіtаtіvе іnfоrmаtіоn and quаntіtаtіvе аnаlуѕіѕ оf vаrіоuѕ ѕеgmеntѕ іn tеrmѕ оf mаrkеt ѕhаrе, grоwth, орроrtunіtу аnаlуѕіѕ, mаrkеt value, еtс. fоr thе fоrесаѕt уеаrѕ. The report offers detailed information regarding the various key players operating in the Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market, their financials, key developments, supply chain trends, technological innovations, apart from future strategies, acquisitions & mergers, market footprint, and COVID-19 Analysis. This report is based on analysis, synthesis, and interpretation of the information gathered regarding the Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market from various sources. We analyzed the data and information and gained insights using primary and secondary research efforts with the primary objective to provide a holistic view of the Global Augmented Reality (AR) and Virtual Reality (VR) in the Healthcare Market. Market Dynamics:
The rising adoption of technologically advanced products and devices and rapid development in the healthcare sector and are major factors driving the growth of the global augmented reality (AR) and virtual reality (VR) in the healthcare market. Also, increasing penetration of the internet of things (IoT) and the rising adoption of connected devices are other factors fueling the growth of the global market. Moreover, the use of augmented and virtual reality for medical training and learning by various institutions and universities is another factor further driving the growth of the global market. The high cost of products and devices is a major factor restraining the growth of the global augmented reality (AR) and virtual reality (VR) in the healthcare market. Also, lack of skilled professionals, data security, and privacy concerns are other factors expected to hamper the growth of the global market to a certain extent over the forecast period. Segmental Analysis:
Among the component segments, the hardware segment is accounted for a major revenue share and is expected to maintain its dominance in the global market. This is attributed to desktops, head-mounted display, and other display devices are of particular importance while using these technologies. Display devices are of great significance since the audio-visual simulation is a key component to create virtual and augmented reality. Head-mounted displays are gaining importance due to their applications in education, simulation, visualized data, video recording, telemedicine, telemonitoring, and many others.
Among the application segments, the patient care management segment is projected to dominate the global market. The use of AR and VR in therapies and rehabilitation would boost the augmented reality in healthcare and virtual reality in the healthcare market. The rehabilitation includes brain injury, stroke, and physical therapy among other applications. Among the end-user segment, the hospitals, clinics, and surgical centers segment are expected to dominate the target market, due to the increasing number of patients with chronic diseases and the growing need for improved patient outcomes. Regional Analysis:
North America accounts for the highest share in the global augmented reality (AR) and virtual reality (VR) in the healthcare market in terms of revenue and is expected to maintain its position over the forecast period. Increasing government and private funding towards the development of these technologies, the presence of major manufacturers and vendors in this region, and early adoption of this technology are major factors driving the growth of North America augmented reality (AR) and virtual reality (VR) in the healthcare market. Europe augmented reality (AR) and virtual reality (VR) in the healthcare market account for the second-highest revenue share in the global market and is expected to witness considerable growth over the next 10 years. The Asia Pacific augmented reality (AR) and virtual reality (VR) in the healthcare market are expected to witness to register the highest CAGR over the next 10 years. Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market Segmentation:
Segmentation by Component: • Hardware • Software • Services Segmentation by Application: • Surgery • Fitness Management • Patient Care Management • Pharmacy Management • Medical Training and Education • Others Segmentation by End-User: • Hospitals, clinics, and surgical centers • Research organizations • Pharma companies • Government • Others Segmentation by region: North America Europe Asia Pacific Latin America Middle East & Africa
Key Players:
Orca Health Inc. Brain Power LLC EchoPixel Inc. MindMaze First Hand Technology Inc. Medical Realities Ltd. zSpace Inc. Microsoft Corporation Alphabet Inc. Magic Leap Inc. Osterhout Design Group Inc.
Scope:
Report Data
Market
Forecast 2022
XX million/billion (2022-2032)
CAGR 2022 - 2032
%
Analysis Period
2022 - 2032
Base Year
2021
Forecast Data
2022 - 2032
Segments Covered
By Type, By Application, And by Regions
Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
1 Introduction (Page No. - 15) 1.1 The objectives of this study 1.2 Market Definition 1.2.1 Market Scope 1.3 Research Methodology 1.4 Stakeholders 1.5 Currency 1.6 Research Assumptions 1.7 Limitation 2 Executive Summary (Page No. - 25)
3. Market Outlook (Page No. - 29) 3.1 Introduction 3.2 DROC Matrix 3.3 Market Challenges 3.4 Market Share Analysis 3.5 Value chain Analysis 3.6 COVID-19 Impacts on Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Industry
4 Industry Trends (Page No. - 42) 4.1 Introduction 4.2 PESTEL Analysis 4.3 Porter’s Five Forces Model 4.3.1 Threat of new entrance 4.3.2 Threat of substitute product 4.3.3 Bargaining power of buyer 4.3.4 Bargaining power of supplier 4.3.5 Intensity of competitive rivalry
5 Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market Component Analysis (Page No. - 51) 5.1 Introduction 5.2 Benchmark Market Revenue Analysis by Component, 2015-2019 5.3 Estimated and Projected Market Analysis by Component, 2020-2030 5.4 Y-o-Y Growth Trend Analysis 5.5 Hardware 5.6 Software 5.7 Services
6A Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market End User Analysis (Page No. - 65) 6A.1 Introduction 6A.2 Benchmark Market Revenue Analysis by End User, 2015-2019 6A.3 Estimated and Projected Market Analysis by End User, 2020-2030 6A.4 Y-o-Y Growth Trend Analysis 6A.5 Hospitals, clinics, and surgical centers 6A.6 Research organizations 6A.7 Pharma companies 6A.8 Government 6A.9 Others
7 Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Regional Analysis (Page No. – 67) 7.1 Introduction 7.2 North America 7.2.1 Benchmark Market Revenue Analysis by Country, 2015-2019 7.2.2 Estimated and Projected Market Analysis by Country, 2020-2030 7.2.3 U.S. 7.2.4 Canada 7.2.5 Mexico 7.3 Europe 7.3.1 Benchmark Market Revenue Analysis by Country, 2015-2019 7.3.2 Estimated and Projected Market Analysis by Country, 2020-2030 7.3.3 U.K. 7.3.4 Germany 7.3.5 France 7.3.6 Rest of Europe 7.4 Asia-Pacific (APAC) 7.4.1 Benchmark Market Revenue Analysis by Country, 2015-2019 7.4.2 Estimated and Projected Market Analysis by Country, 2020-2030 7.4.3 Japan 7.4.4 China 7.4.5 India 7.4.6 Rest of APAC 7.5 Rest of the World (RoW) 7.5.1 Benchmark Market Revenue Analysis by Country, 2015-2019 7.5.2 Estimated and Projected Market Analysis by Country, 2020-2030 7.5.3 Middle East 7.5.4 Africa 7.5.5 Latin America
8 Company Profiles (Page No. - 87) (Overview, Products & Services, Strategies & Insights, recent Developments)* 8.1 Surgical 8.2 CAE HEALTHCARE 8.3 GE Healthcare 8.4 Virtual Realities, LLC 8.5 Philips Healthcare 8.6 3D Systems, Inc. 8.7 Hologic Inc. 8.8 Laerdal Medical TABLE 1 WORLD AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED REGIONAL ANALYSIS, 2020-2030 (USD MILLION) TABLE 2 WORLD AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE BENCHMARK MARKET REVENUE ANALYSIS BY COMPONENT, 2015-2019, (USD MILLION) TABLE 3 WORLD AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 4 WORLD AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE BENCHMARK MARKET REVENUE ANALYSIS BY APPLICATION, 2015-2019, (USD MILLION) TABLE 5 WORLD AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 6 NORTH AMERICA WORLD AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION) TABLE 7 NORTH AMERICA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION) TABLE 8 NORTH AMERICA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 9 NORTH AMERICA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 10 U.S. AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 11 U.S. AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 12 CANADA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 13 CANADA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 14 MEXICO AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 15 CANADA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 16 EUROPE WORLD AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION) TABLE 17 EUROPE AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION) TABLE 18 EUROPE AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 19 EUROPE AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 20 U.K. AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 21 U.K. AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 22 GERMANY AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 23 GERMANY AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 24 FRANCE AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 25 FRANCE AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 26 REST OF EUROPE AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 27 REEST OF EUROPE AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 28 ASIA-PACIFIC WORLD AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION) TABLE 29 ASIA-PACIFIC AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION) TABLE 30 ASIA-PACIFIC AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 31 ASIA-PACIFIC AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 32 JAPAN AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 33 JAPAN AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 34 CHINA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 35 CHINA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 36 INDIA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 37 INDIA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 38 REST OF APAC AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 39 REST OF APAC AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 40 ROW AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION) TABLE 41 ROW AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION) TABLE 42 ROW AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 43 ROW AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 44 MIDDLE EAST AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 45 MIDDLE EAST AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 46 AFRCA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 47 AFRICA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION) TABLE 48 LATIN AMERICA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED COMPONENT ANALYSIS, 2020-2030 (USD MILLION) TABLE 49 LATIN AMERICA AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN HEALTHCARE ESTIMATED AND PROJECTED APPLICATION ANALYSIS, 2020-2030 (USD MILLION)
Frequently Asked Questions
What is the future market value of the ?
The current market value for is expected USD XX million/billion by 2022.
What is the CAGR of the Market?
The is to grow at a CAGR of 5.3% during the forecast by 2032.
What is the Market segment?
On the basis of type, the is segmented into Types.